bioAffinity Technologies, Inc.

Stocks

BIAF

US09076W3079

Market Closed - Nasdaq 16:00:00 2026-08-21 EDT			5-day change	1st Jan Change
0.4000 ^USD	-0.02%		-93.37%	-97.74%

08-18	BioAffinity Technologies, Inc. And AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement For CyPath Lung	CI
08-14	BioAffinity Technologies Closes $4 Million Private Placement	MT

Transcript : BioAffinity Technologies, Inc. - Special Call

Published on 06/16/2026 at 09:20 pm EDT - Modified on 06/17/2026 at 12:05 am EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good evening, and welcome, everyone, to tonight's webinar event. Before we begin, just a few reminders to anyone who is new to the webinar. [Operator

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about bioAffinity Technologies, Inc.

08-18	BioAffinity Technologies, Inc. And AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement For CyPath Lung	CI
08-14	BioAffinity Technologies Closes $4 Million Private Placement	MT
08-13	BioAffinity Technologies, Inc. announced that it has received $3.940766 million in funding	CI
08-11	BioAffinity Technologies, Inc. announced that it expects to receive $3.940766 million in funding	CI
08-07	BioAffinity Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-22	BioAffinity Technologies and Pictor, Inc. Partner to Develop and Commercialize bioAffinity?s Diagnostics for Asthma and COPD	CI
07-21	BioAffinity Technologies, Inc. - Special Call
07-18	Certain Series B Convertible Preferred Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 19-JUL-2026.	CI
07-18	Certain Options of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 19-JUL-2026.	CI
07-18	Certain Warrants of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 19-JUL-2026.	CI
07-18	Certain Common Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 19-JUL-2026.	CI
06-22	BioAffinity Technologies Reports Positive Preclinical Findings for Proprietary Gene Silencing Technology Targeting Squamous and Basal Skin Cancer Cells	CI
06-18	BioAffinity Technologies Closes $3.2 Million Public Offering	MT
06-17	BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%	MT
06-16	BioAffinity Technologies, Inc. - Special Call